We found that the expression of dysadherin and acidosis-related genes in tumors increased with CRC progression, indicating a largely consistent positive correlation in patient tissues (Fig. 1b–d, Supplementary Fig. 1d, f). The gene discussed is FXYD5; the disease is colorectal carcinoma.